Literature DB >> 15072180

False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET--radiological-pathological correlation.

Norio Shiraki1, Masaki Hara, Hiroyuki Ogino, Yuta Shibamoto, Akihiko Iida, Tsuneo Tamaki, Takayuki Murase, Tadaaki Eimoto.   

Abstract

OBJECTIVE: To compare histological findings of FDG-PET false-positive and true-negative hilar and mediastinal lymph nodes.
METHODS: Sixty-seven lymphnode areas in 11 patients who were diagnosed to have N3 lymph nodes by FDG-PET and underwent surgery were histologically examined, and the histopathological findings in false-positive and true-negative lymph nodes were compared. Lymph nodes with higher accumulation of FDG than the surrounding mediastinum level were judged as positive. On histological sections, proportions of macrophages and lymphocytes, amount of coal dust deposit, presence of silicotic nodules, long- and short-axes of the largest node, and volume of macrophages and lymphocytes were evaluated. Correlations between the above-mentioned factors and FDG accumulation were evaluated.
RESULTS: FDG uptake was not correlated with the proportion of macrophages and lymphocytes, coal dust amounts, or the presence of silicotic nodules. The long- and short-axes of the largest node in the false-positive areas were significantly longer than those in the true-negative areas (p = 0.01, and 0.001, respectively). Volumes of lymph nodes (mean +/- SD: 150 +/- 190 mm3) and macrophages (78 +/- 71 mm3) in false-positive areas were markedly larger than those in true-negative areas (68 +/- 87 mm3, p = 0.0009 and 34 +/- 54 mm3, p = 0.0001, respectively). The volume of lymphocytes was also larger in false-positive areas but less markedly.
CONCLUSION: Our study suggested that false-positive results of FDG-PET in hilar and mediastinal lymph nodes were closely related to the size of lymph node and the volume of macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072180     DOI: 10.1007/bf02985610

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  6 in total

Review 1.  Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

Authors:  Christoph Frank Dietrich; Jouke Tabe Annema; Paul Clementsen; Xin Wu Cui; Mathias Maximilian Borst; Christian Jenssen
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice.

Authors:  Evan Nair-Gill; Stephanie M Wiltzius; Xiao X Wei; Donghui Cheng; Mireille Riedinger; Caius G Radu; Owen N Witte
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

3.  Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.

Authors:  Y Tsunezuka; Y Shimizu; N Tanaka; T Takayanagi; M Kawano
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4.  Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.

Authors:  John Cuaron; Mark Dunphy; Andreas Rimner
Journal:  Front Oncol       Date:  2013-01-03       Impact factor: 6.244

5.  Identification of false-negative and false-positive diagnoses of lymph node metastases in non-small cell lung cancer patients staged by integrated (18F-)fluorodeoxyglucose-positron emission tomography/computed tomography: A retrospective cohort study.

Authors:  Kaoru Kaseda; Ken-Ichi Watanabe; Keisuke Asakura; Akio Kazama; Yukihiko Ozawa
Journal:  Thorac Cancer       Date:  2016-05-05       Impact factor: 3.500

6.  Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow.

Authors:  Adam L Kesner; Victoria K Lau; Michael Speiser; Wei-Ann Hsueh; Nzhde Agazaryan; John J DeMarco; Johannes Czernin; Daniel H S Silverman
Journal:  J Appl Clin Med Phys       Date:  2008-06-23       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.